Port site metastasis after minimally invasive surgery of cervical carcinoma: case report and review of the literature

Port site metastasis after minimally invasive surgery in cervical cancer is rare. The authors report a case of port site metastasis in a 45- year-old woman with Stage Ib2 squamous caner of the cervix, together with an update of past 15-year published 12 cases in the literature. It occurred at the port site 18 months after laparoscopic surgery and completion of radiation and chemotherapy. Local excision of the mass was performed and histopathologic examination revealed metastasis of the squamous cell carcinoma of the cervix. The patient was still alive without recurrence and still participating in the follow-up. The authors searched the Medline database to evaluate the incidence, mechanism, relevant factors, preventive measures, treatment, and prognosis of port site metastasis in cervical cancer.

Port site metastasis; Cervical cancer; Minimally invasive surgery.

[1] Tjalma W.A., Winter-Roach B.A., Rowlands P., De B.L.A.: “Port-site recurrence following laparoscopic surgery in cervical cancer”. Int. J. Gynecol. Cancer., 2001, 11, 409.

[2] Gregor H., Sam C.E., Reinthaller A., Joura E.A.: “Port site metastases after laparoscopic lymph node staging of cervical carcinoma”. J. Am. Assoc. Gyn. Lap., 2001, 8, 591-593.

[3] Agostini A., Cohen D., Cravello L., Bretelle F., Roger V., Blanc B.: “Portsite recurrence following laparoscopic para-aortic lymphadenectomy for squamous carcinoma of the cervix”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 98, 258.

[4] Picone O., Aucouturier J.S., Louboutin A., Coscas Y., Camus E.: “Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literature”. Gynecol. Oncol., 2003, 90, 446.

[5] Martínezpalones J.M., Gilmoreno A., Pérezbenavente M.A., Garciagiménez A., Xercavins J.: “Umbilical metastasis after laparoscopic retroperitoneal paraaortic lymphadenectomy for cervical cancer: a true port-site metastasis?”. Gynecol. Oncol., 2005, 97, 292.

[6] Park J.Y., Lim M.C., Lim S.Y., Bae J.M., Yoo C.W., Seo S.S., et al.: “Portsite and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer”. Int. J. Gynecol. Cancer., 2008, 18, 176.

[7] Yenen M.C., Dede M., Alanbay I., Ustün Y., Gültekin M., Ayhan A.: “Port-site metastasis after laparoscopic extraperitoneal paraaortic lymphadenectomy for stage iib squamous cell carcinoma of the cervix”. J. Minim. Invas. Gyn., 2009, 16, 227-230.

[8] Sert B.: “Robotic port-site and pelvic recurrences after robot-assisted laparoscopic radical hysterectomy for a stage IB1 adenocarcinoma of the cervix with negative lymph nodes”. Int. J. Med. Robot. Comp., 2010, 6, 132.

[9] Bolles O., Borowsky M.: “Port-site metastasis following robotic-assisted radical hysterectomy for squamous cell cervical cancer”. Gynecol. Oncol., 2012, 2, 32.

[10] Kim B.K., Huh S.J., Kim B.G.: “Port site metastasis after robotic-assisted laparoscopic hysterectomy for uterine cervical cancer: a case report and literature review”. Taiwan. J. Obstet. Gynecol., 2013, 52, 558.

[11] Ota T., Huang K.G., Sicam R.V.G., Lee C.L.: “Abdominal wall port-site metastasis after hand-port assisted laparoscopic splenectomy in recurrent cervical cancer”. Springer Jpn., 2013, 2, 131.

[12] Shivam K., Anamaria Y., Kristianna F., Julie G.: “Cervical cancer with a rare umbilical metastases in prior surgical site”. Int. J. Surg., 2015, 17, 8.

[13] Reymond M.A., Schneider C., Kastl S., Hohenberger W., Köckerling F.: “The pathogenesis of port-site recurrences”. J. Gastrointest. Surg., 1998, 2, 406.

[14] Ramirez P.T, Wolf J.K, Levenback C.: “Laparoscopic port-site metastases: etiology and prevention”. Gynecol. Oncol., 2003, 91, 179.

[15] Zivanovic O., Sonoda Y., Diaz J.P., Levine D.A., Brown C.L., Chi D.S., et al.: “The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease”. Gynecol. Oncol.,

2008, 111, 431.

[16] Nagarsheth N.P., Rahaman J., Cohen C.J., Gretz H., Nezhat F.: “The incidence of port-site metastases in gynecologic cancers”. JSLS, 2004, 8, 133.

[17] Ndofor B.T., Soliman P.T., Schmeler K.M., Nick A.M., Frumovitz M., Ramirez P.T.: “Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies”. Int. J. Gynecol. Cancer, 2011, 21, 936.

[18] Rindos N., Curry C.L., Tabbarah R., Wright V.: “Port-site metastases after robotic surgery for gynecologic malignancy”. JSLS, 2014, 18, 66.

[19] Ziprin P., Ridgway P.F., Peck D.H., Darzi A.W.: “The theories and realities of port-site metastase: A critical appraisal”. J. Am. Coll. Surgeons, 2002, 195, 395.

[20] Mo X., Yang Y., Lai H., Xiao J., He K., Chen J., et al.: “Does carbon dioxide pneumoperitoneum enhance wound metastases following laparoscopic abdominal tumor surgery? A meta-analysis of 20 randomized control studies”. Tumor. Biol., 2014, 35, 7351.

[21] Wang P.H., Yuan C.C., Lin G., Ng H.T., Chao H.T.: “Risk Factors Contributing to Early Occurrence of Port Site Metastases of Laparoscopic Surgery for Malignancy”. Gynecol. Oncol., 1999, 72, 38.

[22] Agostini A., Robin F., Jais J.P., Aggerbeck M., Vildé F., Blanc B., et al.: “Peritoneal closure reduces port site metastases”. Surg. Endosc., 2002, 16, 289.

[23] Lönnerfors C., Bossmar T., Persson J.: “Port-site metastases following robot-assisted laparoscopic surgery for gynecological malignancies”. Acta Obstet. Gyn. Scan., 2013, 92, 1361.

[24] Agostini A., Carcopino X., Franchi F., Cravello L., Lécuru F., Blanc B.: “Port site metastasis after laparoscopy for uterine cervical carcinoma”. Surg. Endos., 2003, 17, 1663.

[25] Curet M.J.: “Port site metastases”. Am. J. Surg., 2004, 187, 705.

[26] Papadia A., Moya Y., Rodgers S.E., Diaz J.P.: “Surgical resection of recurrent upper abdominal cervical cancer: a case report and review of the literature”. Gynecol. Oncol., 2011, 1, 8.

[27] Monk B.J., Sill M.W., Mcmeekin D.S., Cohn D.E., Ramondetta L.M., Boardman C.H., et al.: “Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study”. J. Clin. Oncol., 2009, 27, 4649.